BiotechTube

NAV5001

Phase 3Terminated
0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Parkinson's Syndrome

Conditions

Parkinson's Syndrome

Trial Timeline

Nov 1, 2013 → Jan 1, 2018

NCT ID
NCT01950455

About NAV5001

NAV5001 is a phase 3 stage product being developed by Navidea Biopharmaceuticals for Parkinson's Syndrome. The current trial status is terminated. This product is registered under clinical trial identifier NCT01950455. Target conditions include Parkinson's Syndrome.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson's Syndrome were approved

Approved (20) Terminated (3) Active (0)
✅Lemborexant + placeboEisaiApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved
✅carbidopa/levodopa + Carbidopa/Levodopa/EntacaponeNovartisApproved
✅carbidopa, levodopa, entacaponeNovartisApproved
✅Levodopa/carbidopa/entacapone + Levodopa/carbidopaNovartisApproved

Hype Score Breakdown

Clinical
17
Activity
0
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01950455Phase 3Terminated

Competing Products

20 competing products in Parkinson's Syndrome

See all competitors
ProductCompanyStageHype Score
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
GPI 1485EisaiPhase 2
35
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
E2007 + E2007 + E2007EisaiPhase 2
35
E2007EisaiPhase 2
35
E2007EisaiPhase 2
27
E2007EisaiPhase 2
27
2 mg perampanel + 4 mg perampanel + placebo comparatorEisaiPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 2
35
Istradefylline 20 mg or 40 mgKyowa KirinPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 3
40